SW

Stephen Donald Wilton

UA University Of Western Australia: 35 patents #1 of 158Top 1%
MU Murdoch University: 5 patents #1 of 19Top 6%
UM Universite De Mons: 3 patents #1 of 46Top 3%
ST Sarepta Therapeutics: 2 patents #36 of 64Top 60%
MU Monash University: 2 patents #62 of 420Top 15%
Overall (All Time): #62,455 of 4,157,543Top 2%
46
Patents All Time

Issued Patents All Time

Showing 1–25 of 46 patents

Patent #TitleCo-InventorsDate
11898143 Agents useful in treating facioscapulohumeral muscular dystrophy Alexandra Belayew, Frederique Coppee, Celine Vanderplanck, Eugenie Ansseau 2024-02-13
11674143 Modulators and modulation of the receptor for advanced glycation end-products RNA Merlin Christopher THOMAS, Carlos Rosado, Raelene Jane PICKERING 2023-06-13
11459563 Treatment for NEAT1 associated disease Sue Fletcher, Archa Fox, Ruohan Li 2022-10-04
11447776 Antisense molecules and methods for treating pathologies Sue Fletcher, Abbie Adams, Penny Meloni 2022-09-20
11441148 Modulators and modulation of the receptor for advanced glycation end-products RNA Merlin Christopher THOMAS, Carlos Rosado, Raelene Jane PICKERING 2022-09-13
RE48960 Antisense oligonucleotides for inducing exon skipping and methods of use thereof Sue Fletcher, Graham McClorey 2022-03-08
11236338 Antisense-induced exon2 inclusion in acid alpha-glucosidase Sue Fletcher, Gunnar J. Hanson, Richard K. Bestwick 2022-02-01
11053494 Methods and materials for activating an internal ribosome entry site in exon 5 of the DMD gene Kevin Flanigan, Nicolas Sebastien Wein 2021-07-06
10995337 Antisense oligonucleotides for inducing exon skipping and methods of use thereof Sue Fletcher, Graham McClorey 2021-05-04
10968450 Antisense oligonucleotides for inducing exon skipping and methods of use thereof Sue Fletcher, Graham McClorey 2021-04-06
10907157 Agents useful in treating facioscapulohumeral muscular dystrophy Alexandra Belayew, Frederique Coppee, Celine Vanderplanck, Eugenie Ansseau 2021-02-02
10781450 Antisense molecules and methods for treating pathologies Sue Fletcher, Abbie Adams, Penny Meloni 2020-09-22
10781451 Antisense oligonucleotides for inducing exon skipping and methods of use thereof Sue Fletcher, Graham McClorey 2020-09-22
10731156 Restoration of the CFTR function by splicing modulation Batsheva Kerem, Michal Tur Sinai, Loren Price, Sue Fletcher 2020-08-04
RE47769 Antisense oligonucleotides for inducing exon skipping and methods of use thereof Sue Fletcher, Graham McClorey 2019-12-17
RE47751 Antisense oligonucleotides for inducing exon skipping and methods of use thereof Sue Fletcher, Graham McClorey 2019-12-03
RE47691 Antisense oligonucleotides for inducing exon skipping and methods of use thereof Sue Fletcher, Graham McClorey 2019-11-05
10428328 Restoration of the CFTR function by splicing modulation Batsheva Kerem, Michal Tur Sinai, Loren Price, Sue Fletcher 2019-10-01
10421966 Antisense oligonucleotides for inducing exon skipping and methods of use thereof Sue Fletcher, Graham McClorey 2019-09-24
10376536 Multiple sclerosis treatment Sue Fletcher, May Aung-Htut 2019-08-13
10266827 Antisense oligonucleotides for inducing exon skipping and methods of use thereof Sue Fletcher, Graham McClorey 2019-04-23
10227590 Antisense oligonucleotides for inducing exon skipping and methods of use thereof Sue Fletcher, Graham McClorey 2019-03-12
9994851 Antisense oligonucleotides for inducing exon skipping and methods of use thereof Sue Fletcher, Graham McClorey 2018-06-12
9988628 Agents useful in treating facioscapulohumeral muscular dystrophy Alexandra Belayew, Frederique Coppee, Celine Vanderplanck, Eugenie Ansseau 2018-06-05
9758783 Antisense molecules and methods for treating pathologies Sue Fletcher, Abbie Adams, Penny Meloni 2017-09-12